TITLE

Amantadine use in influenza outbreaks in long-term care facilities

AUTHOR(S)
Tamblyn, Susan E.
PUB. DATE
December 1997
SOURCE
CMAJ: Canadian Medical Association Journal;12/01/97, Vol. 157 Issue 11, p1573
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Reports on the use of the antiviral drug amantadine to abort influenza A outbreaks in long-term care facilities. Contingency plans; Deciding whether amantadine should be used; Monitoring side effects; Treating ill residents.
ACCESSION #
9712150263

 

Related Articles

  • How to beat the flu.  // Consumer Reports;Nov2000, Vol. 65 Issue 11, p64 

    Offers advice on how to prevent and treat influenza. Statement by the United States Centers for Disease Control and Prevention (CDC) that everyone age 50 and over should get a flu shot; Use of antiviral drugs, such as amantadine and zanamivir, to combat the flu; Common symptoms of influenza,...

  • Scientists Disagree to Disagree on Influenza A Channel Structure. Breindl, Anette // BioWorld Today;1/31/2008, Vol. 19 Issue 21, p1 

    The article reports on two research groups, which presented in the January 31, 2008 issue of "Nature," what each believes to be the binding mechanism of the anti-influenza drug amantadine to its target, the M2 channel. It was noted that the two groups agree on the basic structure of the channel,...

  • Amantadine: Does It Have a Role in the Prevention and Treatment of Influenza? A National Institutes of Health Consensus Development Conference. Delker, Laryl Lee; Moser, Robert H.; Nelson, John D.; Rodstein, Manuel; Rolls, Karl; Sanford, Jay P.; Swartz, Morton N. // Annals of Internal Medicine;Feb80 Part 1, Vol. 92 Issue 2, p256 

    Summarizes conclusions on amantadine hydrochloride reached at a conference held at the U.S. National Institutes of Health on October 15-16, 1979. Benefits from amantadine hydrochloride in the treatment of influenza type A; Risks of the uses of amantadine hydrochloride for the prophylaxis and...

  • Initiating Influenza Chemoprophylaxis with the First Influenza Case: A New Institutional Standard? Gravenstein, Stefan // Clinical Infectious Diseases;7/1/2008, Vol. 47 Issue 1, p53 

    The author comments on the study about the use of amantadine chemoprophylaxis at the beginning of an influenza outbreak to reduce its duration. He argues that the method have underestimated the prevalence of influenza and the potential impact of chemoprophylaxis. He notes that in the study,...

  • Amantadine Effect on Peripheral Airways Abnormalities in Influenza. Little, John W.; Hall, William J.; Douglas, R. Gordon; Hyde, Richard W.; Speers, Donna M. // Annals of Internal Medicine;Aug76, Vol. 85 Issue 2, p177 

    Presents a study which evaluated the potential therapeutic efficacy of amantadine HC1 in modifying lower respiratory airway abnormalities in documented naturally occurring influenza A infection. Methods for pulmonary function testing; Resolution of clinical illness; Rate of resolution of...

  • Effect of Timing of Amantadine Chemoprophylaxis on Severity of Outbreaks of Influenza A in Adult Long-Term Care Facilities. Rubin, Marcie S.; Nivin, Beth; Ackelsberg, Joel // Clinical Infectious Diseases;7/1/2008, Vol. 47 Issue 1, p47 

    Background. Long-term care facilities (LTCFs) are vulnerable to outbreaks of influenza. There are limited data on the impact of antiviral chemoprophylaxis on the duration of outbreaks of influenza. We investigated the association of timely initiation of amantadine chemoprophylaxis on the...

  • Amantadine for Dysphagia in the Elderly.  // OB/GYN Clinical Alert;Aug2011 Clinical Briefs in Primary, p15 

    The article focuses on the amantadine (AMTD), a drug for the treatment of influenza which is being investigated by clinicians as a potential treatment for dysphagia in the elderly.

  • Treatment of chronic hepatitis C patients with amantadine. Yagura, Michiyasu; Harada, Hideharu // Journal of Gastroenterology;2001, Vol. 36 Issue 11, p759 

    Background. Amantadine was reported to decrease serum alanine aminotransferase and HCV RNA levels in chronic hepatitis C patients who had not respond to interferon, but further experience has produced mixed results. The aim of this study was to investigate the efficacy and safety of amantadine...

  • New treatments for hepatitis C.  // Patient Care;7/15/1996, Vol. 30 Issue 12, p14 

    Reports on the potential of amantadine HC1 as a less expensive alternative to interferon alfa-2b, for treatment of chronic hepatitis C infection. Response of patients in a pilot study; Response rate for amantadine; Cost of the regimen.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics